...
首页> 外文期刊>Sleep & breathing =: Schlaf & Atmung >Stage-matched intervention for adherence to CPAP in patients with obstructive sleep apnea: a randomized controlled trial.
【24h】

Stage-matched intervention for adherence to CPAP in patients with obstructive sleep apnea: a randomized controlled trial.

机译:阻塞性睡眠呼吸暂停患者坚持CPAP的阶段匹配干预:一项随机对照试验。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The objective of the study was to evaluate the effectiveness of stage-matched intervention on adherence to continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea syndrome.One hundred and ten Chinese patients with newly diagnosed obstructive sleep apnea syndrome were enrolled in this study. They were randomly assigned into stage-matched care (SMC) and standard care (SC) groups (55 patients in each group). Patients in the SMC group received stage-matched intervention at different stages of behavior changes, and the SC group received only routine care. The intervention was based on the health action process approach theory and included risk perception, outcome expectancy, and self-efficacy. Questionnaires included the Self-Efficacy Measure for Sleep Apnea, the Epworth Sleepiness Scale (ESS), and the Pittsburgh Sleep Quality Index (PSQI). Data were collected at baseline and 1 and 3 months after home CPAP treatment, and hours of CPAP usage was also recorded at 1 and 3 months of follow-up.At 1 month, CPAP usage was 5.59?±?0.56 hight (mean ± SD) vs 5.28?±?0.67 hight in the SMC and SC groups, respectively (p?=?0.016). At 3 months, CPAP usage was 5.65?±?0.50 vs 5.26?±?0.82 hight in the SMC and SC groups, respectively (p?=?0.006). Repeated ANOVA analysis demonstrated that risk perception, outcome expectancy, and self-efficacy in the SMC group were significantly higher than those of the SC group (p?
机译:本研究的目的是评估阶段性干预对阻塞性睡眠呼吸暂停综合症患者坚持持续气道正压通气(CPAP)的有效性。本研究招募了110名中国新诊断为阻塞性睡眠呼吸暂停综合症的患者研究。他们被随机分为阶段匹配治疗(SMC)和标准治疗(SC)组(每组55例)。 SMC组的患者在行为改变的不同阶段接受阶段匹配的干预,SC组仅接受常规护理。干预措施基于健康​​行动过程方法理论,包括风险感知,预期结果和自我效能感。问卷包括对睡眠呼吸暂停的自我效能测量,爱泼华嗜睡量表(ESS)和匹兹堡睡眠质量指数(PSQI)。在基线期以及家庭CPAP治疗后1和3个月收集数据,并在随访的1和3个月记录CPAP的使用小时数.1个月时,CPAP的使用率为5.59±0.56 h /晚(平均分别为SMC和SC组的5.28±±0.67 h / night(p = 0.016)。在3个月时,SMC和SC组的CPAP用量分别为5.65±0.50 h /夜与5.26±0.82 h /晚(p = 0.006)。重复的方差分析表明,SMC组的风险感知,预期结果和自我效能显着高于SC组(p <0.05)。此外,时间×小组互动对结果预期和自我效能感显着,表明在三个时间点上,小组在结果预期和自我效能的变化上有显着差异。 CPAP治疗3个月后,SMC和SC组在ESS(p <0.001)和PSQI(p0.01 = 0.013)的改善方面有显着差异。相匹配的干预不仅可以促进意图形成并提高了治疗的自我效能,但显着提高了OSA患者在3个月的治疗中对CPAP的依从性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号